Therapy News and Research

RSS

Rare abdominal cancer diagnosis being looked at in a different manner

Their experience treating a rare type of abdominal cancer has helped physicians at Wake Forest University Baptist Medical Center make a new discovery that may change the way it is diagnosed.

24 Apr 2006

Non-Smokers with lung cancer respond better to treatment than smokers

Smoking history contributes to poor outcomes in the treatment of lung cancer, according to a new study. Non-small cell lung cancer (NSCLC) lung cancer patients who have never smoked before in their life have better overall survival rates and respond better to chemotherapy than current or former smokers.

24 Apr 2006

Kidney treatments may be improved with new understanding of cell death mechanism

Finding how two proteins conspire to get kidney cells to self-destruct when oxygen supplies are low may one day improve dismal mortality rates for ischemic renal failure, researchers say.

23 Apr 2006

Novel approach used to neutralize anthrax toxin

Researchers from Rensselaer Polytechnic Institute and the University of Toronto have designed a nanoscale assembly of molecules that successfully counteracts and inhibits anthrax toxin in animal and laboratory experiments.

23 Apr 2006

Link between expectancy, visual cues and the desire to smoke

In a study recently published in the journal Neuropsychopharmacology, researchers at the Montreal Neurological Institute (MNI) and the Department of Psychology at McGill University found that when people expect to smoke in the near future, external cues such as watching someone smoke affects their brain more than their level of craving or how long they have gone without a cigarette.

23 Apr 2006

Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia

New clues to why some kinds of leukemia are more aggressive and deadly than others are coming from research examining the types of genetic damage that allow some blood cells to grow out of control, scientists report.

23 Apr 2006

HRT can reduce heart attacks by about one-third in women under age 60

For the last few years, women have heard conflicting reports about the risks and benefits of hormone replacement therapy (HRT). A new study that analyzes many trials together concludes that HRT can reduce heart attacks by about one-third in women under age 60 but has mixed results for older women.

23 Apr 2006

Drug combo might beat type 1 diabetes

Scientists in California have developed a cocktail of drugs which can reverse diabetes and say the discovery is an important step towards a potential cure.

23 Apr 2006

Hypnotherapy relieves chest pain not linked to heart disease

According to a small study in the UK, hypnotherapy was helpful in relieving the angina-like chest pain experienced by some people which is not caused by heart disease.

23 Apr 2006

Popular antidepressants may affect fetus

A team from the Ottawa Health Research Institute, the University of Ottawa, and The Ottawa Hospital has found an increased risk of premature delivery, low birth weight, fetal death, and infant seizures among pregnant women who used a popular class of antidepressants during pregnancy.

20 Apr 2006

Surgical robot makes prostate removal safe for obese men

The use of a robotic system could make surgery for prostate cancer an option for thousands of obese men who might otherwise be turned down, report researchers from the University of Chicago in the April 2006 issue of the journal Urology.

20 Apr 2006

New medical device improves blood pressure control

Physicians at the Hypertension and Vascular Disease Center at Wake Forest University Baptist Medical Center have proven that a new medical device improves blood pressure management in patients with the most common form of uncontrolled hypertension.

19 Apr 2006

Treating populations infected with both HIV and latent TB could speed the emergence of drug-resistant TB

In 2005, 46 regional Ministers of Health in Africa declared that a dramatic rise in tuberculosis (TB) cases was cause for emergency.

19 Apr 2006

St. Jude develop strategy to speed future development of more effective and less toxic treatments for medulloblastoma

Investigators at St. Jude Children’s Research Hospital have developed a strategy to speed future development of more effective and less toxic treatments for medulloblastoma, a type of brain cancer. Medulloblastomas arise in the back of the brain and account for about 20 percent of childhood brain tumors.

18 Apr 2006

Music may be a good complement to pain-relief drugs

Medication is the best, first choice to treat pain following surgery, but music may be a good complement to pain-relief drugs, according to a new review of clinical studies.

18 Apr 2006

Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus

Fast-acting artificial insulin drugs work just as well as regular human insulin, but it's unclear how they could affect the health of people with diabetes over the long run, according to a new review of recent studies.

18 Apr 2006

Antibiotics for exacerbations of chronic obstructive pulmonary disease

People with chronic obstructive pulmonary disease often experience short term worsening and aggravation of their symptoms.

18 Apr 2006

Directly observed therapy for treating tuberculosis

Directly observed therapy (DOT) has no quantitatively important effect on cure rates or treatment completion in people receiving treatment for tuberculosis (TB).

18 Apr 2006

Inhaled corticosteroids ease asthma symptoms

Adults and children with asthma will breathe deeper and have better control over their asthma with inhaled corticosteroids than with the medicine cromolyn, according to a new review of recent studies comparing the two treatments.

18 Apr 2006

Prostate cancer research may be faster with prostate-specific antigen endpoints

A new study from Columbia University Medical Center researchers at NewYork-Presbyterian Hospital/Columbia, who are members of the Southwest Oncology Group (SWOG), suggests that certain changes in prostate-specific antigen (PSA) levels may serve as surrogate endpoints for prostate cancer survival.

18 Apr 2006